Zhuo Li

发表

Association of NKG2D genetic polymorphism with susceptibility to chronic hepatitis B in a Han Chinese population

Jing-yun Li, Xi-lin Zhu, Xiaopan Wu, 2010, Journal of medical virology.

Association of-238G/A and -857C/T polymorphisms of tumor necrosis factor-alpha gene promoter region with outcomes of hepatitis B virus infection.

Y. Liu, Jun-hong Li, Zhuo Li, 2006, Biomedical and environmental sciences : BES.

Association of polymorphism of tumor necrosis factor-alpha gene promoter region with outcome of hepatitis B virus infection.

Y. Liu, Jun-hong Li, Zhuo Li, 2005, World journal of gastroenterology.

Replication of Genome Wide Association Studies on Hepatocellular Carcinoma Susceptibility Loci in a Chinese Population

Y. Liu, Xi-lin Zhu, Xiaopan Wu, 2013, PloS one.

Association of epidermal growth factor and epidermal growth factor receptor polymorphisms with the risk of hepatitis B virus-related hepatocellular carcinoma in the population of North China.

Y. Liu, A. Xu, Xi-lin Zhu, 2013, Genetic testing and molecular biomarkers.

Endoplasmic Reticulum Stress-Activated Glycogen Synthase Kinase 3β Aggravates Liver Inflammation and Hepatotoxicity in Mice with Acute Liver Failure

Dexi Chen, Z. Duan, Hongbo Shi, 2015, Inflammation.

JAK1 gene polymorphisms are associated with the outcomes of hepatitis B virus infection, but not with α interferon therapy response in a Han Chinese population.

Y. Liu, Xi-lin Zhu, Xiaopan Wu, 2012, Genetic testing and molecular biomarkers.

Evaluation of susceptibility locus for response to interferon-α based therapy in chronic hepatitis B patients in Chinese.

Xi-lin Zhu, Xiaopan Wu, Y. Liu, 2012, Antiviral research.

A pharmacogenetic study of polymorphisms in interferon pathway genes and response to interferon-alpha treatment in chronic hepatitis B patients.

Jing-yun Li, Xi-lin Zhu, Xiaopan Wu, 2009, Antiviral research.

Association between epidermal growth factor 61A/G polymorphism and hepatocellular carcinoma susceptibility in Chinese patients

Jingmin Zhao, F. Lu, H. Zhuang, 2010, Liver international : official journal of the International Association for the Study of the Liver.

Genetic variation in STAT4 predicts response to interferon‐α therapy for hepatitis B e antigen‐positive chronic hepatitis B

Jianfeng Xu, S. Zheng, Ying Liu, 2016, Hepatology.

A functional polymorphism in ADAR1 gene affects HBsAg seroclearance both spontaneously and interferon induced

Y. Liu, Z. Duan, Xi-lin Zhu, 2014, Liver international : official journal of the International Association for the Study of the Liver.

Polymorphisms in ADAR1 gene affect response to interferon alpha based therapy for chronic hepatitis B in Han Chinese.

Y. Liu, Xi-lin Zhu, Xiaopan Wu, 2012, Antiviral research.

Human leukocyte antigen class I and class II genes polymorphisms might be associated with interferon α therapy efficiency of chronic hepatitis B.

N. Niu, Xi-lin Zhu, T. Du, 2011, Antiviral research.

A novel immunoassay for PreS1 and/or core-related antigens for detection of HBsAg variants.

X. Hao, N. Xia, Jun Zhang, 2010, Journal of virological methods.

A missense polymorphism in ATF6 gene is associated with susceptibility to hepatocellular carcinoma probably by altering ATF6 level

Y. Liu, Z. Duan, Xi-lin Zhu, 2014, International journal of cancer.

Evaluation of Genetic Susceptibility Loci for Chronic Hepatitis B in Chinese: Two Independent Case-Control Studies

X. Miao, Y. Liu, L. Wang, 2011, PloS one.

ADAR1 stimulation by IFN-α downregulates the expression of MAVS via RNA editing to regulate the anti-HBV response.

Ying Liu, Wei Li, Xiaoshuang Yang, 2020, Molecular therapy : the journal of the American Society of Gene Therapy.

Genome-wide association study identiﬁes 8p21.3 associated with persistent hepatitis B virus infection among Chinese

Hongbing Shen, Zhibin Hu, Weihua Jia, 2022 .

Germline Duplication of SNORA18L5 Increases Risk for HBV-related Hepatocellular Carcinoma by Altering Localization of Ribosomal Proteins and Decreasing Levels of p53.

Weihua Jia, Ying Wang, F. He, 2018, Gastroenterology.

A 3′ UTR SNP in COL18A1 Is Associated with Susceptibility to HBV Related Hepatocellular Carcinoma in Chinese: Three Independent Case-Control Studies

Y. Liu, Xi-lin Zhu, Xiaopan Wu, 2012, PloS one.

Polymorphisms in the VEGFA promoter are associated with susceptibility to hepatocellular carcinoma by altering promoter activity

Xi-lin Zhu, Xiaopan Wu, Y. Liu, 2013, International journal of cancer.

Polymorphisms in the potential functional regions of the TGF‐β 1 and TGF‐β receptor genes and disease susceptibility in HBV‐related hepatocellular carcinoma patients

Y. Liu, A. Xu, Xi-lin Zhu, 2012, Molecular carcinogenesis.

[Study on association between vitamin D receptor gene polymorphisms and the outcomes of HBV infection].

Y. Liu, Xi-lin Zhu, Xin-hui Guo, 2006, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.

Endoplasmic Reticulum Stress-Activated Glycogen Synthase Kinase 3β Aggravates Liver Inflammation and Hepatotoxicity in Mice with Acute Liver Failure

Dexi Chen, Z. Duan, Hongbo Shi, 2015, Inflammation.

Association of HLA-DQB1 gene polymorphisms with outcomes of HBV infection in Chinese Han population.

Y. Liu, Xi-lin Zhu, T. Du, 2007, Swiss medical weekly.

[Association of TNFA polymorphisms with the outcomes of HBV infection].

Ying Liu, Xi-lin Zhu, T. Du, 2005, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.

Kaempferol induces apoptosis in HepG2 cells via activation of the endoplasmic reticulum stress pathway.

Z. Duan, Hai-Qing Guo, Xiangying Zhang, 2016, Molecular medicine reports.

Association of TNF‐alpha promoter polymorphisms with the outcomes of hepatitis B virus infection in Chinese Han population

J-H Li, Xi-lin Zhu, T. Du, 2006, Journal of viral hepatitis.

The 20th Conference of the Asian Pacific Association for the Study of the Liver Poster Presentation

H. Shin, H. Cheong, Y. Kim, 2010, Hepatology International.

Genetic variation in STAT4 predicts response to interferon‐α therapy for hepatitis B e antigen‐positive chronic hepatitis B

Jianfeng Xu, Ying Liu, D. Lu, 2016, Hepatology.